![]() |
Prosigna Breast Cancer Prognostic Gene Signature Assay predicts ROR in women with ear
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced results from two studies that are featured in oral presentations this week at IMPAKT Breast Cancer Conference.
More... |
| All times are GMT -7. The time now is 10:12 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021